The UK NSC has held the inaugural meeting of the partnership board which will oversee the development of the in-service evaluation of newborn screening for spinal muscular atrophy in real world NHS services.
We have published updated information on paid-for commercial screening tests and how they differ from quality-assured end-to-end NHS screening programmes
The UK NSC has updated its guidance and processes for individuals working with the committee to declare any interests that may conflict, or be perceived to conflict, with that work.
There were nearly 290,000 separate visits to the UK NSC's 3 online platforms during 2023, reflecting the committee's ongoing commitment to continually improve its stakeholder engagement.
Recent Comments